HR 4811 · 117th Congress 2021–2023, ended

Medicare Negotiation and Competitive Licensing Act of 2021

Latest action · Sep 8, 2021 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJul 29, 2021
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Medicare Negotiation and Competitive Licensing Act of 2021

This bill establishes several requirements relating to the prices of prescription drugs.

Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under Medicare. (Current law prohibits the CMS from doing so.) If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under health insurance programs, notwithstanding existing government-granted exclusivities.

The negotiated prices also apply to other federal health care programs, private health insurance, and the uninsured; pharmacies that charge more than the negotiated price for uninsured individuals are subject to civil penalties. Manufacturers must also comply with specified reporting requirements relating to prices and licensing, subject to civil penalties.

The bill also institutes an excise tax on drugs for which the price spikes beyond a certain limit, subject to specified exemptions, as well as on drugs for which the price exceeds the negotiated price.

Cosponsors 79

Members who signed on, in the order they did. Signatures ran from Jul 29, 2021 to Dec 14, 2022; 57 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-NYAdriano EspaillatOriginalJul 29, 2021
D-TXAl GreenOriginalJul 29, 2021
D-CAAlan S. LowenthalOriginalJul 29, 2021
D-NYAlexandria Ocasio-CortezOriginalJul 29, 2021
D-NJAndy KimOriginalJul 29, 2021
D-MIAndy LevinOriginalJul 29, 2021
D-MAAyanna PressleyOriginalJul 29, 2021
D-CABarbara LeeOriginalJul 29, 2021
D-MSBennie G. ThompsonOriginalJul 29, 2021
D-CABrad ShermanOriginalJul 29, 2021
D-MEChellie PingreeOriginalJul 29, 2021
D-MOCori BushOriginalJul 29, 2021
D-RIDavid N. CicillineOriginalJul 29, 2021
D-MIDebbie DingellOriginalJul 29, 2021
D-NVDina TitusOriginalJul 29, 2021

Committees 5

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jul 29, 2021
Health Subcommittee
Referred Jul 30, 2021
HouseWays and Means Committee
Referred Jul 29, 2021
Health Subcommittee
Referred Jul 29, 2021
HouseOversight and Government Reform Committee
Referred Jul 29, 2021
HouseVeterans' Affairs Committee
Referred Jul 29, 2021
Health Subcommittee
Referred Sep 8, 2021
HouseArmed Services Committee
Referred Jul 29, 2021

Actions 5

Everything that happened, newest first.

  1. Sep 8, 2021Referred to the Subcommittee on Health.
  2. Jul 30, 2021Referred to the Subcommittee on Health.
  3. Jul 29, 2021Introduced in House
  4. Jul 29, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. Jul 29, 2021Referred to the Subcommittee on Health.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Clause 1 of Section 8 of Article I of the United States Constitution.

The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 133, July 29, 2021, page H4294.

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of drugs furnished under the Medicare program, and for other purposes.
Short Title(s) as Introduced
Medicare Negotiation and Competitive Licensing Act of 2021

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Jul 29, 2021Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.